Viridian Therapeutics, Inc.\DE (VRDN) Other Working Capital Changes (2021 - 2025)
Viridian Therapeutics, Inc.\DE's (VRDN) quarterly Other Working Capital Changes came in at -$72000.0 in Q2 2025, little changed year-on-year from -$72000.0 in Q2 2024, and little changed quarter-over-quarter from -$72000.0 in Q1 2025.
Viridian Therapeutics, Inc.\DE (VRDN) Other Working Capital Changes (2021 - 2025) Analysis & Trends
Viridian Therapeutics, Inc.\DE's Other Working Capital Changes history runs 5 years deep, the most recent figure standing at -$72000.0 for Q2 2025.
- On a quarterly basis, Other Working Capital Changes changed 0.0% year-over-year to -$72000.0 in Q2 2025; TTM through Jun 2025 was -$288000.0, a 0.0% change from a year earlier, with the FY2024 full-year figure at -$288000.0, changed 0.0% from the prior year.
- Other Working Capital Changes steadied at -$72000.0 in Q2 2025 per VRDN's latest filing, from -$72000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $8.6 million in Q4 2025 and bottomed at -$5.2 million in Q2 2025.
- The 5-year median for Other Working Capital Changes is $780000.0 (2022), against an average of $1.1 million.
- Biggest YoY gain for Other Working Capital Changes was 51.68% in 2022; the steepest drop was 107.76% in 2022.
- Year by year, Other Working Capital Changes stood at -$71000.0 in 2021, then decreased by 1.41% to -$72000.0 in 2022, then changed by 0.0% to -$72000.0 in 2023, then changed by 0.0% to -$72000.0 in 2024, then changed by 0.0% to -$72000.0 in 2025.
- Per Business Quant, the three latest VRDN Other Working Capital Changes figures stand at -$72000.0 (Q2 2025), -$72000.0 (Q1 2025), and -$72000.0 (Q4 2024).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Viridian Therapeutics, Inc.\DE | 631.55 Mn | 631.55 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -72,000.00 |
| Jun 30, 2025 | -72,000.00 |
| Jun 30, 2025 | -72,000.00 |
| Mar 31, 2025 | -72,000.00 |
| Mar 31, 2025 | -72,000.00 |
| Mar 31, 2025 | -72,000.00 |
| Dec 31, 2024 | -72,000.00 |
| Dec 31, 2024 | -72,000.00 |
| Dec 31, 2024 | -72,000.00 |
| Sep 30, 2024 | -72,000.00 |
| Sep 30, 2024 | -72,000.00 |
| Sep 30, 2024 | -72,000.00 |
| Jun 30, 2024 | -72,000.00 |
| Jun 30, 2024 | -72,000.00 |
| Jun 30, 2024 | -72,000.00 |
| Mar 31, 2024 | -72,000.00 |
| Mar 31, 2024 | -72,000.00 |
| Mar 31, 2024 | -72,000.00 |
| Dec 31, 2023 | -72,000.00 |
| Dec 31, 2023 | -72,000.00 |